CAI
Price
$24.29
Change
-$0.49 (-1.98%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
6.99B
Intraday BUY SELL Signals
PROK
Price
$2.29
Change
-$0.39 (-14.55%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
380.05M
Intraday BUY SELL Signals
Interact to see
Advertisement

CAI vs PROK

Header iconCAI vs PROK Comparison
Open Charts CAI vs PROKBanner chart's image
Caris Life Sciences
Price$24.29
Change-$0.49 (-1.98%)
Volume$23.46K
Capitalization6.99B
ProKidney
Price$2.29
Change-$0.39 (-14.55%)
Volume$14.3K
Capitalization380.05M
CAI vs PROK Comparison Chart in %
CAI
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CAI vs. PROK commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAI is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CAI: $24.77 vs. PROK: $2.68)
Brand notoriety: CAI and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAI: 114% vs. PROK: 76%
Market capitalization -- CAI: $6.99B vs. PROK: $380.05M
CAI [@Biotechnology] is valued at $6.99B. PROK’s [@Biotechnology] market capitalization is $380.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAI’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CAI’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both CAI and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAI’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 4 bullish TA indicator(s).

  • CAI’s TA Score: 4 bullish, 4 bearish.
  • PROK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CAI is a better buy in the short-term than PROK.

Price Growth

CAI (@Biotechnology) experienced а -15.20% price change this week, while PROK (@Biotechnology) price change was -0.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($6.99B) has a higher market cap than PROK($380M). PROK YTD gains are higher at: 58.580 vs. CAI (-55.768). PROK has higher annual earnings (EBITDA): -157.52M vs. CAI (-186.94M). CAI has more cash in the bank: 721M vs. PROK (295M). PROK has less debt than CAI: PROK (4.42M) vs CAI (419M). CAI has higher revenues than PROK: CAI (534M) vs PROK (527K).
CAIPROKCAI / PROK
Capitalization6.99B380M1,839%
EBITDA-186.94M-157.52M119%
Gain YTD-55.76858.580-95%
P/E RatioN/AN/A-
Revenue534M527K101,328%
Total Cash721M295M244%
Total Debt419M4.42M9,484%
FUNDAMENTALS RATINGS
CAI: Fundamental Ratings
CAI
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CAIPROK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 29 days ago
65%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 8 days ago
60%
Bearish Trend 9 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CAI
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUMMF0.04N/A
+7.69%
AuMEGA Metals Ltd
FEGIX53.731.58
+3.03%
First Eagle Gold I
CGEAF46.990.18
+0.38%
Cogeco Communications Inc
TFOAX83.26-0.14
-0.17%
Touchstone Focused A
HYSR0.03N/A
-1.16%
SunHydrogen Inc.

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
-1.55%
BMEA - CAI
35%
Loosely correlated
-2.14%
VTGN - CAI
23%
Poorly correlated
+0.99%
LIXT - CAI
20%
Poorly correlated
+7.71%
CRDF - CAI
20%
Poorly correlated
-2.18%
PROK - CAI
20%
Poorly correlated
-4.29%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-4.29%
RLYB - PROK
45%
Loosely correlated
-0.96%
NRIX - PROK
39%
Loosely correlated
-5.37%
APGE - PROK
38%
Loosely correlated
+0.24%
KYMR - PROK
37%
Loosely correlated
+0.25%
ZYME - PROK
37%
Loosely correlated
-1.58%
More